Clinical Trials Directory

Trials / Completed

CompletedNCT06721130

Role of 18F-FDG PET/CT in the Evaluation of Cavernous Sinus Syndrome: a Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
54 (actual)
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cavernous sinus syndrome (CSS) can be caused by a wide range of inflammatory, malignant, benign, vascular and miscellaneous disorders. Even after modern advances, reaching the final etiological diagnosis remains a challenge in CSS. This study is planned to determine the role and incremental value of 18F-FDG PET/CT in characterising different cavernous sinus pathologies based on their metabolic activity and detecting extracranial involvement.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTFDG radiotracerPilot study evaluating the role of FDG PET/CT in Cavernous sinus syndrome

Timeline

Start date
2022-07-01
Primary completion
2023-12-31
Completion
2024-06-30
First posted
2024-12-06
Last updated
2024-12-06

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT06721130. Inclusion in this directory is not an endorsement.